Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials.

MLA

Leiter, Lawrence A., et al. “Inclisiran in Individuals with Diabetes or Obesity: Post Hoc Pooled Analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 Randomized Trials.” Diabetes, Obesity & Metabolism, vol. 26, no. 8, Aug. 2024, pp. 3223–37. EBSCOhost, https://doi.org/10.1111/dom.15650.

APA

Leiter, L. A., Raal, F. J., Schwartz, G. G., Koenig, W., Ray, K. K., Landmesser, U., Han, J., Conde, L. G., & Wright, R. S. (2024). Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials. Diabetes, Obesity & Metabolism, 26(8), 3223–3237. https://doi.org/10.1111/dom.15650

Chicago

Leiter, Lawrence A, Frederick J Raal, Gregory G Schwartz, Wolfgang Koenig, Kausik K Ray, Ulf Landmesser, Jackie Han, Lorena Garcia Conde, and R Scott Wright. 2024. “Inclisiran in Individuals with Diabetes or Obesity: Post Hoc Pooled Analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 Randomized Trials.” Diabetes, Obesity & Metabolism 26 (8): 3223–37. doi:10.1111/dom.15650.